These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 18823685

  • 1. Rituximab treatment of fibrillary glomerulonephritis.
    Collins M, Navaneethan SD, Chung M, Sloand J, Goldman B, Appel G, Rovin BH.
    Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Successful use of rituximab in fibrillary glomerulopathy.
    Chaudhary A, Gyamlani G, Cossey NL, Walker PD, Wall BM.
    Ren Fail; 2014 Aug; 36(7):1151-4. PubMed ID: 24831880
    [Abstract] [Full Text] [Related]

  • 8. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches.
    Fabrizi F, Lunghi G, Messa P, Martin P.
    J Nephrol; 2008 Aug; 21(6):813-25. PubMed ID: 19034865
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis.
    Pandrangi S, Singh A, Wheeler DE, Rossi NF.
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):393-7. PubMed ID: 18493239
    [Abstract] [Full Text] [Related]

  • 11. Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness.
    Dickenmann M, Schaub S, Nickeleit V, Mihatsch M, Steiger J, Brunner F.
    Am J Kidney Dis; 2002 Sep; 40(3):E9. PubMed ID: 12200826
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
    Roll P, Dörner T, Tony HP.
    Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
    [Abstract] [Full Text] [Related]

  • 13. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
    Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S.
    Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
    [Abstract] [Full Text] [Related]

  • 14. Rituximab for idiopathic membranous nephropathy: who can benefit?
    Ruggenenti P, Chiurchiu C, Abbate M, Perna A, Cravedi P, Bontempelli M, Remuzzi G.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):738-48. PubMed ID: 17699281
    [Abstract] [Full Text] [Related]

  • 15. Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia.
    Korte MR, van Heerde MJ, de Man RA, Betjes MH.
    Neth J Med; 2008 Jan; 66(1):27-30. PubMed ID: 18219065
    [Abstract] [Full Text] [Related]

  • 16. Fibrillary-immunotactoid glomerulopathy with renal deposits of IgAlambda: a rare cause of glomerulonephritis.
    van Ginneken EE, Assmann KJ, Koolen MI, Jansen JL, Wetzels JF.
    Clin Nephrol; 1999 Dec; 52(6):383-9. PubMed ID: 10604647
    [Abstract] [Full Text] [Related]

  • 17. [Monoclonal antibodies to B-lymphocytes (rituximab) in the treatment of HCV-associated severe cryoglobulinemic glomerulonephritis].
    Milovanova SIu, Lopatkina TN, Kozlovskaia LV, Krasnova TN.
    Ter Arkh; 2007 Dec; 79(6):69-72. PubMed ID: 17684972
    [No Abstract] [Full Text] [Related]

  • 18. Fibrillary glomerulonephritis: a report of 2 cases with extensive glomerular and tubular deposits.
    Adeyi OA, Sethi S, Rennke HG.
    Hum Pathol; 2001 Jun; 32(6):660-3. PubMed ID: 11431723
    [Abstract] [Full Text] [Related]

  • 19. Resolution of IgM nephropathy after rituximab treatment.
    Betjes MG, Roodnat JI.
    Am J Kidney Dis; 2009 Jun; 53(6):1059-62. PubMed ID: 19084309
    [Abstract] [Full Text] [Related]

  • 20. Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.
    von Bonin M, Oelschlägel U, Radke J, Stewart M, Ehninger G, Bornhauser M, Platzbecker U.
    Transplantation; 2008 Sep 27; 86(6):875-9. PubMed ID: 18813113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.